Leukemia Clinical Trials in Pittsburgh

Showing 601-620 of 822 trials

Registry for Integrative Medicine Interventions Effectiveness

NCT01754038

This registry will perform prospective surveillance of participants attending collaborating Integrative Medicine clinic sites for clinical services. All decisions about medication use, treatments, visit frequency, assessment of tolerance, and other aspects of patient management will be left to the clinical providers' discretion. We will attempt to follow the participants in the PRIMIER Registry for up to 2 years. Essential data elements that capture patient-reported outcomes and measures of clinical activity will be obtained at approximately 2-month intervals for the first 6 months, then every 6 months through the end of year 2.

All Conditions of Integrative Medicine Clinic Patients

BraveNet5,069 participantsStarted Aug 2013

La Jolla, California, United States • San Francisco, California, United States • Santa Monica, California, United States +11 more locations

COMPLETEDPHASE3< 1 mile

A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

NCT01846611

The purpose of this study is to assess the efficacy and safety of trabectedin+DOXIL as a third-line chemotherapy regimen (treatment) in patients with platinum-sensitive advanced-relapsed epithelial ovarian, primary peritoneal, or fallopian tube cancer who received 2 previous lines of platinum-based chemotherapy.

Ovarian NeoplasmsPeritoneal NeoplasmsFallopian Tube Neoplasms

Janssen Research & Development, LLC581 participantsStarted Oct 2013

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Scottsdale, Arizona, United States +135 more locations

Registry for Integrative Medicine Interventions Effectiveness

A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Leukemia Trials in Other Cities

Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML

Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder

Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome

Early Diagnosis of Candidiasis in Premature Infants

Antenatal Phenobarbital to Prevent Neonatal Intracranial Hemorrhage

Persistent Pulmonary Hypertension of the Newborn (PPHN) Observational Study

Efficacy and Safety Study of Idelalisib in Participants With Indolent B-Cell Non-Hodgkin Lymphomas

BAY1436032 in Patients With Mutant IDH1(mIDH1) Advanced Acute Myeloid Leukemia (AML)

Study of Sapacitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)

A Randomized, Double-Blind, Placebo-Controlled Study of Idelalisib in Combination With Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL)

A Study of LY2510924 in Participants With Extensive-Stage Small Cell Lung Carcinoma

PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And Erlotinib

A Phase I, Multicenter Dose Escalation Study in Patients With Hairy Cell Leukemia

Idelalisib in Combination With Rituximab for Previously Untreated Follicular Lymphoma and Small Lymphocytic Lymphoma

LDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung Cancer

Comparability and Standardization of Controlled Allergen Challenge Facilities

A Study for Patients With Acute Leukemia

Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia

Other Conditions in Pittsburgh